In the third installment of our special series in partnership with bioMérieux, Luis welcomes back Dr. Sonali Kalathiya, infectious diseases pharmacist and medical advisor at bioMérieux, to explore how innovation is accelerating antimicrobial susceptibility testing (AST).

Together they dive into FAST AST—a phenotypic susceptibility test that delivers actionable results directly from positive blood cultures in hours instead of days. They discuss how this technology works, how it complements molecular testing, and how it's transforming patient care, antimicrobial stewardship, and laboratory workflows.

From implementation and training to real-world clinical impact, this episode uncovers what it truly means to diagnose resistance at the speed of AST.

🎧 Tune in to learn how faster results are helping clinicians act sooner, optimize therapy, and improve patient outcomes.

This episode is sponsored by bioMérieux, a global innovator in infectious disease diagnostics.

Resources from this episode:

• bioMérieux Sepsis Webinar

• https://info.biomerieux.com/clin_us_2024_ams_handbook?utm_source=podcast&utm_medium=show-notes&utm_campaign=LetsTalkMicro

Stay connected with Let's Talk Micro:

• Website: letstalkmicro.com

• Questions or feedback? Email me at [email protected]

• Interested in being a guest on Let's Talk Micro? Fill out the form here: https://forms.gle/V2fT3asjfyusmqyi8

Support the podcast:

• Venmo

• Buy me a Ko-fi